Skip to main navigation
About Us
Management
Board of Directors
Partnering
History
Pipeline
Prasinezumab
PRX004
Publications
Investors
Investors
Overview
Press Releases
Events & Presentations
Financials & Filings
SEC Filings
Quarterly Results
Key Ratios
Irish Statutory Financial Statements
Corporate Governance
Committee Composition
Stock Information
Historic Stock Lookup
Investment Calculator
Analyst Coverage
Patients
Amyloidosis
Parkinson’s Disease
Clinical Trials
Expanded Access
Careers
Core Values
Compensation and Benefits
Opportunities
Public House
Contact Us
Event Details
Phase 2 PASADENA Study Results
Sep 15, 2020
1:30 PM EDT
Webcast Presentation
Listen to webcast
Event Details
Title
Phase 2 PASADENA Study Results
Date and Time
Sep 15, 2020
1:30 PM EDT
Shareholder Tools
Email Alerts
Download Library
RSS News Feeds
Print
Share
Facebook
Google
LinkedIn
Twitter
RSS
Close
Scroll to top
